AP NEWS
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Globe Newswire
Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Market Trends Toward New Normal in Smartsheet, Spok, TPG RE Finance Trust, DSP Group, Adaptimmune Therapeutics, and Aquestive Therapeutics — Emerging Consolidated Expectations, Analyst Ratings

April 9, 2019

NEW YORK, April 09, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Smartsheet Inc. (NYSE:SMAR), Spok Holdings, Inc. (NASDAQ:SPOK), TPG RE Finance Trust, Inc. (NYSE:TRTX), DSP Group, Inc. (NASDAQ:DSPG), Adaptimmune Therapeutics PLC (NASDAQ:ADAP), and Aquestive Therapeutics, Inc. (NASDAQ:AQST), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

SMAR DOWNLOAD: http://Capital-Review.com/register/?so=SMAR SPOK DOWNLOAD: http://Capital-Review.com/register/?so=SPOK TRTX DOWNLOAD: http://Capital-Review.com/register/?so=TRTX DSPG DOWNLOAD: http://Capital-Review.com/register/?so=DSPG ADAP DOWNLOAD: http://Capital-Review.com/register/?so=ADAP AQST DOWNLOAD: http://Capital-Review.com/register/?so=AQST

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Capital Review, available for free download at the links above, examine Smartsheet Inc. (NYSE:SMAR), Spok Holdings, Inc. (NASDAQ:SPOK), TPG RE Finance Trust, Inc. (NYSE:TRTX), DSP Group, Inc. (NASDAQ:DSPG), Adaptimmune Therapeutics PLC (NASDAQ:ADAP), and Aquestive Therapeutics, Inc. (NASDAQ:AQST) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today’s readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

SMARTSHEET INC. (SMAR) REPORT OVERVIEW

Smartsheet’s Recent Financial Performance

For the three months ended January 31st, 2019 vs January 31st, 2018, Smartsheet reported revenue of $52.15MM vs $32.96MM (up 58.22%) and analysts estimated basic earnings per share $0.30 vs -$0.44. For the twelve months ended January 31st, 2019 vs January 31st, 2018, Smartsheet reported revenue of $177.72MM vs $111.25MM (up 59.75%) and analysts estimated basic earnings per share -$0.65 vs -$2.94. Analysts expect earnings to be released on June 3rd, 2019. The report will be for the fiscal period ending April 30th, 2019. The reported EPS for the same quarter last year was -$0.21. The estimated EPS forecast for the next fiscal year is -$0.96 and is expected to report on March 17th, 2020.

To read the full Smartsheet Inc. (SMAR) report, download it here: http://Capital-Review.com/register/?so=SMAR

-----------------------------------------

SPOK HOLDINGS, INC. (SPOK) REPORT OVERVIEW

Spok’s Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Spok reported revenue of $43.26MM vs $43.77MM (down 1.17%) and analysts estimated basic earnings per share -$0.04 vs -$1.06. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Spok reported revenue of $169.47MM vs $171.18MM (down 0.99%) and analysts estimated basic earnings per share -$0.08 vs -$0.76. Analysts expect earnings to be released on April 24th, 2019. The report will be for the fiscal period ending March 31st, 2019.

To read the full Spok Holdings, Inc. (SPOK) report, download it here: http://Capital-Review.com/register/?so=SPOK

-----------------------------------------

TPG RE FINANCE TRUST, INC. (TRTX) REPORT OVERVIEW

TPG RE Finance Trust’s Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, TPG RE Finance Trust reported revenue of $36.58MM vs $31.47MM (up 16.25%) and analysts estimated basic earnings per share $0.42 vs $0.39 (up 7.69%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, TPG RE Finance Trust reported revenue of $140.88MM vs $122.33MM (up 15.16%) and analysts estimated basic earnings per share $1.70 vs $1.74 (down 2.30%). Analysts expect earnings to be released on May 6th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.42. The estimated EPS forecast for the next fiscal year is $1.81 and is expected to report on February 24th, 2020.

To read the full TPG RE Finance Trust, Inc. (TRTX) report, download it here: http://Capital-Review.com/register/?so=TRTX

-----------------------------------------

DSP GROUP, INC. (DSPG) REPORT OVERVIEW

DSP Group’s Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, DSP Group reported revenue of $26.06MM vs $31.24MM (down 16.60%) and basic earnings per share -$0.02 vs -$0.01. For the twelve months ended December 31st, 2018 vs December 31st, 2017, DSP Group reported revenue of $117.44MM vs $124.75MM (down 5.86%) and analysts estimated basic earnings per share -$0.09 vs -$0.14. Analysts expect earnings to be released on April 29th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.01. The estimated EPS forecast for the next fiscal year is $0.36 and is expected to report on February 3rd, 2020.

To read the full DSP Group, Inc. (DSPG) report, download it here: http://Capital-Review.com/register/?so=DSPG

-----------------------------------------

ADAPTIMMUNE THERAPEUTICS PLC (ADAP) REPORT OVERVIEW

Adaptimmune Therapeutics’ Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Adaptimmune Therapeutics reported revenue of $1.48MM vs $4.27MM (down 65.36%) and analysts estimated basic earnings per share -$0.30 vs -$0.23. For the twelve months ended December 31st, 2018 vs December 31st, 2017, Adaptimmune Therapeutics reported revenue of $59.51MM vs $37.83MM (up 57.28%) and analysts estimated basic earnings per share -$0.96 vs -$0.78. Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.24. The estimated EPS forecast for the next fiscal year is -$1.20 and is expected to report on February 26th, 2020.

To read the full Adaptimmune Therapeutics PLC (ADAP) report, download it here: http://Capital-Review.com/register/?so=ADAP

-----------------------------------------

AQUESTIVE THERAPEUTICS, INC. (AQST) REPORT OVERVIEW

Aquestive Therapeutics’ Recent Financial Performance

Analysts expect earnings to be released on June 13th, 2019. The report will be for the fiscal period ending March 31st, 2019. The estimated EPS forecast for the next fiscal year is -$1.28 and is expected to report on March 12th, 2020.

To read the full Aquestive Therapeutics, Inc. (AQST) report, download it here: http://Capital-Review.com/register/?so=AQST

-----------------------------------------

ABOUT CAPITAL REVIEW

Capital Review is a nationally recognized publisher of financial analysis, research reports, and exclusive market reporting. Institutional investors, registered brokers, professional traders, and personal investment advisers rely on Capital Review to quantify public company valuations, discover opportunity across asset classes, stay informed about market-moving events, and read exclusive analysis of important material developments. With 14 offices worldwide, Capital Review staffs and manages certified and registered financial professionals, including Chartered Financial Analyst® (CFA®) designation holders and FINRA® BrokerCheck® certified individuals with current and valid CRD® number designations, to enable continuous coverage of topics relevant to its regular active reader base.

REGISTERED MEMBER STATUS

Capital Review’s oversight and audit staff are registered analysts, brokers, and/or financial advisers (“Registered Members”) working within Equity Research, Media, and Compliance departments. Capital Review’s roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Capital Review have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Capital Review’s Compliance department by Phone, at +1 (410) 280-7496, or by E-mail at compliance@Capital-Review.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Capital Review, Capital Review members, and/or Capital Review affiliates are not responsible for any gains or losses that result from the opinions expressed. Capital Review makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Capital Review has not been compensated for the publication of this press release by any of the above mentioned companies. Capital Review is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact: Morena Zambada, Media Department Office: +1 (410) 280-7496 E-mail: media@Capital-Review.com

© 2019 Capital Review. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Capital-Review.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.